The ability to track cancer's genetic secrets through a simple blood draw is no longer a futuristic concept but a clinical reality facing its own set of critical challenges. For years, the field of oncology has been steadily moving away from invasive tissue biopsies toward liquid biopsies, a
Biopharma expert Ivan Kairatov joins us to discuss a groundbreaking advance in immunotherapy. While treatments like CAR-T cell therapy have shown incredible promise, they are not a solution for every patient, often because the necessary immune cells are rare or difficult to work with. Now,
A formidable new strategy has emerged in the fight against a particularly stubborn form of lung cancer, offering a beacon of hope for patients whose tumors have developed resistance to frontline treatments. Researchers from the Medical University of Vienna have pioneered a novel combination therapy
A conservative West Virginia lawmaker and a progressive California governor rarely find common ground, yet they have become improbable allies in a sweeping national movement to fundamentally reshape what Americans eat and how public health is managed. This decentralized but powerful crusade,
For one of the most aggressive forms of breast cancer, the very molecular machinery that fuels its relentless growth has now been identified as its most critical and exploitable vulnerability, opening a new front in the war against this disease. This groundbreaking discovery shifts the focus from
For decades, oncology has relied on a static snapshot of a tumor, a single frame from a complex biological film, to guide treatment decisions. The Cancer Digital Twin Technology represents a significant advancement in personalized medicine and oncology. This review will explore the evolution of the
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78